Back to results
US 2021/0171546 A1Published application
Methods of preparing cytotoxic benzodiazepine derivatives
AssigneeImmunoGen, Inc.
InventorsBaudouin Gérard, Manami Shizuka, Michael Louis Miller, Richard A. Silva
Life of this patent
Estimating the term…
Abstract
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
Claims21
1-25. (canceled)
A method of preparing a compound of formula (20A):
- or a salt thereof, said method comprising the step of reacting a brominating or iodinating reagent with a compound of formula (14A):
- or a salt there of, wherein
- X3 is —Cl;
- and
- X5 is —Br or —I.
2 more elements
A method of preparing a compound of formula (18A):
- or a pharmaceutically acceptable salt thereof, comprising the steps of:
- (1) reacting a brominating or iodinating reagent with a compound of formula (14A):
- or a salt there of, to form a compound of formula (20A):
- or a salt thereof;
- (2) reacting the compound of formula (20A) or a salt thereof with a monomer compound of formula (d1):
- to form a compound of formula (17A):
- or a salt thereof;
- (3) reacting the compound of formula of (17A) or a salt thereof with a monomer compound of formula (b1):
- to form the compound of formula (18A) or a pharmaceutically acceptable salt thereof, wherein:
- X3 is —Cl;
- X5 is —Br or —I;
- and
- P3 is H or an amine protecting group.
10 more elements
A method of preparing a compound of formula (IA):
- or a pharmaceutically acceptable salt thereof, comprising the steps of:
- (1) reacting a brominating or iodinating reagent with a compound of formula (14A):
- or a salt thereof, to form a compound of formula (20A):
- or a salt thereof;
- (2) reacting the compound of formula (20A) or a salt thereof with a monomer compound of formula (b1):
- to form a compound of formula (16A):
- or a salt thereof;
- (3) reacting the compound of formula (16A) or a salt thereof with an imine reducing agent to form a compound of formula (17A′):
- or a salt thereof;
- (4) reacting the compound of (17A′) or a salt thereof with a monomer of formula (b1):
- to form the compound of formula (IA) or a pharmaceutically acceptable salt thereof, wherein:
- X3 is —Cl;
- and
- X5 is —Br or —I.
11 more elements
Dependencies are inferred from the claim text.